CR20140374A - Nuevos usos pediatricos del cabazitaxel - Google Patents

Nuevos usos pediatricos del cabazitaxel

Info

Publication number
CR20140374A
CR20140374A CR20140374A CR20140374A CR20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A CR 20140374 A CR20140374 A CR 20140374A
Authority
CR
Costa Rica
Prior art keywords
cabazitaxel
pediatric uses
new pediatric
new
compound
Prior art date
Application number
CR20140374A
Other languages
English (en)
Inventor
S Sidhu Sukhvinder
Patricia Vrignaud
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of CR20140374A publication Critical patent/CR20140374A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Epoxy Compounds (AREA)

Abstract

La presente invención se refiere al compuesto de fórmula (I):
CR20140374A 2012-02-10 2014-08-07 Nuevos usos pediatricos del cabazitaxel CR20140374A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305151 2012-02-10
EP12306352 2012-10-30
PCT/EP2013/052518 WO2013117683A1 (en) 2012-02-10 2013-02-08 New pediatric uses of cabazitaxel

Publications (1)

Publication Number Publication Date
CR20140374A true CR20140374A (es) 2014-12-01

Family

ID=47714075

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20140374A CR20140374A (es) 2012-02-10 2014-08-07 Nuevos usos pediatricos del cabazitaxel

Country Status (21)

Country Link
US (1) US20140350273A1 (es)
EP (1) EP2811996A1 (es)
JP (1) JP2015509929A (es)
KR (1) KR20140129091A (es)
CN (1) CN104334172A (es)
AU (1) AU2013217964A1 (es)
BR (1) BR112014019675A2 (es)
CA (1) CA2864029A1 (es)
CL (1) CL2014002118A1 (es)
CO (1) CO7030963A2 (es)
CR (1) CR20140374A (es)
EA (1) EA201491506A1 (es)
GT (1) GT201400173A (es)
HK (1) HK1199398A1 (es)
IL (1) IL234015A0 (es)
MX (1) MX2014009610A (es)
NZ (1) NZ628565A (es)
PH (1) PH12014501794A1 (es)
SG (1) SG11201404712UA (es)
WO (1) WO2013117683A1 (es)
ZA (1) ZA201405815B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain
FR2859996B1 (fr) * 2003-09-19 2006-02-03 Aventis Pharma Sa Solvat acetonique du dimethoxy docetaxel et son procede de preparation
CN102781237A (zh) * 2009-11-23 2012-11-14 天蓝制药公司 用于传递治疗剂的基于环糊精的聚合物

Also Published As

Publication number Publication date
US20140350273A1 (en) 2014-11-27
HK1199398A1 (en) 2015-07-03
IL234015A0 (en) 2014-09-30
EA201491506A1 (ru) 2014-12-30
KR20140129091A (ko) 2014-11-06
ZA201405815B (en) 2015-11-25
SG11201404712UA (en) 2014-09-26
BR112014019675A2 (pt) 2017-07-11
CO7030963A2 (es) 2014-08-21
NZ628565A (en) 2016-03-31
CA2864029A1 (en) 2013-08-15
CL2014002118A1 (es) 2015-06-26
GT201400173A (es) 2015-08-13
MX2014009610A (es) 2015-09-25
WO2013117683A1 (en) 2013-08-15
CN104334172A (zh) 2015-02-04
EP2811996A1 (en) 2014-12-17
AU2013217964A1 (en) 2014-08-28
PH12014501794A1 (en) 2014-11-24
JP2015509929A (ja) 2015-04-02

Similar Documents

Publication Publication Date Title
CR20140510A (es) Nucleósidos de espirooxetano de uracilo
CY1119105T1 (el) Παραγωγα διπυραζολιου ως αναστολεις jak
CR20140042A (es) Indazoles
CR20150271A (es) Peptidos como agonistas de oxitocina
CR20140463A (es) Compuestos de heterociclilo como inhibidores de mek
CR20140132A (es) Derivados de pirrolopirimidina y purina
CR20150370A (es) Compuestos antivirales
CR20140535A (es) Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa
EA201790963A1 (ru) Противовирусные соединения
CR20130129A (es) Anàlogos de buprenorfina
CR20140435A (es) Nuevos derivados de tienopirimidina, procesos para su preparacion y sus usos terapeuticos
CR20150084A (es) 2-oxo-2,3-dihidro-indoles
CR20140468A (es) Inhibidores de diacilglicerol aciltransferasa 2
ECSP14013327A (es) Compuestos con actividad nematicida
CR20150069A (es) Pirrolopirazoles como bloqueadores del canal de calcio tipo n
EA201491817A1 (ru) Терапевтическое применение продуктов из косточек винограда шардоне
CR20140094A (es) Derivados de etinilo
CR20140322A (es) Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2
ECSP13012366A (es) Procedimiento de preparación de la sal de l-arginina de perindoprilo
CR20130475A (es) Derivados de etinilo
CR20150144A (es) Derivados de etinilo como moduladores del receptor de actividad mglur5
CR20140528A (es) Difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos como inhibidores de Bace1
CU20150006A7 (es) Derivados de (piperidin-4-il)piperazina-1-carboxamida/carboxilato útiles como antagonistas del receptor -h3
CR20140124A (es) Metabolitos de transclomifeno y usos de los mismos
CR20150087A (es) Derivados de pirazol-carboxamida